Alembic Pharmaceuticals, with a legacy dating back to 1907, has emerged as a venerable presence in the pharmaceutical industry, consistently achieving notable milestones. The company has positioned itself as a leading, vertically integrated healthcare entity, showcasing proficiency in the production of high-quality finished dosage forms, bulk drugs (APIs), and intermediates. This success has translated into global recognition and market penetration across 50 countries, with a strong presence in strategic markets such as Europe, the UK, and the USA. Alembic's reputation is further bolstered by its cutting-edge manufacturing facilities in Gujarat and Sikkim, as well as state-of-the-art research and development centres in Vadodara, Hyderabad, and the USA, keeping the company at the forefront of pharmaceutical innovation. Ongoing efforts and strategic investments underscore Alembic's commitment to sustained success.